<unk>  is a gonadotropin that is FDA approved for the procedure of induction of ovulation in women who have previously received pituitary suppression and development of multiple follicles as part of an assisted reproductive technology (ART) cycle in ovulatory women who have previously received pituitary suppression.   Common adverse reactions include headache, hot flashes, OHSS, pain, respiratory disorder, abdominal cramps, abdominal fullness/enlargement, nausea, pelvic pain, and post retrieval pain.
Urofollitropin
Follitropin beta
Follitropin alfa
Psilocin
Choriogonadotropin alfa
Icterogenin
Bryostatin
EpiPen